Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. (Q30355795)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

20 June 2017

Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. (English)

1 reference

Europe PubMed Central

20 June 2017

Mycobacterium tuberculosis

0 references

1 reference

based on heuristic

inferred from title

Steven A Porcelli

9

object named as

Steven A Porcelli

1 reference

Europe PubMed Central

20 June 2017

author name string

Vasan K Sambandamurthy

1

1 reference

Europe PubMed Central

20 June 2017

Steven C Derrick

2

1 reference

Europe PubMed Central

20 June 2017

Tsungda Hsu

3

1 reference

Europe PubMed Central

20 June 2017

Bing Chen

4

1 reference

Europe PubMed Central

20 June 2017

Michelle H Larsen

5

1 reference

Europe PubMed Central

20 June 2017

Kripa V Jalapathy

6

1 reference

Europe PubMed Central

20 June 2017

Mei Chen

7

1 reference

Europe PubMed Central

20 June 2017

John Kim

8

1 reference

Europe PubMed Central

20 June 2017

John Chan

10

1 reference

Europe PubMed Central

20 June 2017

Sheldon L Morris

11

1 reference

Europe PubMed Central

20 June 2017

William R Jacobs

12

1 reference

Europe PubMed Central

20 June 2017

language of work or name

0 references

publication date

12 June 2006

1 reference

Europe PubMed Central

20 June 2017

1 reference

Europe PubMed Central

20 June 2017

24

1 reference

Europe PubMed Central

20 June 2017

37-39

1 reference

Europe PubMed Central

20 June 2017

6309-6320

1 reference

Europe PubMed Central

20 June 2017

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Variation in protection by BCG: implications of and for heterologous immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Human immunodeficiency virus infection and routine childhood immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Disseminated bacille Calmette-Guérin disease after vaccination: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Tuberculosis: from genome to vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

The tuberculosis vaccine challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Has BCG attenuated to impotence?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Comparative genomics of BCG vaccines by whole-genome DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

The in vitro evolution of BCG vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.097

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.05.097

1 reference

Europe PubMed Central

20 June 2017

1 reference

Europe PubMed Central

20 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30355795&oldid=1636789903"